Delivery Order SPE2DB20D3103-SPE2DB22FN7U7
Award Date
5/31/22
Potential Completion Date
6/1/22
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation. The $3,989.02 delivery order is for the pharmaceutical product Renflexis 100 mg vials. The IDC has a potential value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $1,242.50 and runs through December 12, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a...
This firm fixed price delivery order, valued at $14,897.76, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract provides the supply of Renflexis 100 mg vials, a specialty pharmaceutical product, with a performance period through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100mg vials of the drug Renflexis. The contract has a ceiling value of $4,039.92 and runs through January 3, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 100mg vials of the drug Renflexis, at a firm fixed price of $33,482.21. The award does not have a set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure pharmaceutical and medical supplies from AmerisourceBergen to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,529.60 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564712042 RENFLEXIS 100 MG VIALS. This contract has an ultimate completion date of May 28, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,399.20 to provide RENFLEXIS 100 MG VIALS. This delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $3,941.28 and a completion date of January 31, 2022. It is a firm fixed-price contract without any set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RENFLEXIS 100 MG VIALS. The contract is a firm fixed-price delivery order with a ceiling value of $35,556.83 and an ultimate completion date of August 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RENFLEXIS 100 MG VIALS. The order has a ceiling value of $7,925.94 and is a firm fixed price contract type. The ultimate completion date for this delivery order is September 24, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...